Enable your JavaScript to use Numstock


Numstock » ACRS

ACRS Stock Analysis

The latest metrics for Aclaris Therapeutics, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -0.44
Price / Book Value Ratio < 1.5 0.89
Price / Sales Ratio < 2.0 8.43
PEG Ratio < 1.0 -0.13
EV / EBITDA Ratio < 8.0 -0.13
Price / FCF Ratio Last Year < 15.0 -0.45
Price / FCF Ratio Last Quarter < 15.0 -3.28
Price / TBV Ratio Last Year < 0.7 0.49
Price / TBV Ratio Last Quarter < 0.7 0.96
Price / NCAV Ratio Last Year < 0.7 0.51
Price / NCAV Ratio Last Quarter < 0.7 1.07

Efficiency

Metric Target Value
ROE Last Year > 25.0% -60.28
ROE Last Quarter > 25.0% -49.72
ROA Last Year > 15.0% -48.17
ROA Last Quarter > 15.0% -34.48
ROTA Last Year > 20.0% -83.62
ROTA Last Quarter > 20.0% -14.25
ROIC Last Year > 20.0% -56.36
ROIC Last Quarter > 20.0% -21.17
ROCE Last Year > 20.0% -54.04
ROCE Last Quarter > 20.0% -17.18
Inventory Turnover Last Year > 4.0 8.66
Inventory Turnover Last Quarter > 4.0 0.0
Pre-tax Margin Last Year > 20.0% -1665
Pre-tax Margin Last Quarter > 20.0% -7124
Accounts Payable Turnover Last Year > 3.0 0.46
Accounts Payable Turnover Last Quarter > 3.0 0.05
Accounts Receivable Turnover Last Year > 5.0 1.41
Accounts Receivable Turnover Last Quarter > 5.0 0.17

Health

Metric Target Value
Current Ratio Last Year > 1.5 6.56
Current Ratio Last Quarter > 1.5 5.32
Quick Ratio Last Year > 1.5 6.54
Quick Ratio Last Quarter > 1.5 5.32
Flow Ratio Last Year < 1.25 4.48
Flow Ratio Last Quarter < 1.25 4.22
Debt / Equity Ratio Last Year < 0.5 0.14
Debt / Equity Ratio Last Quarter < 0.5 0.35
Debt / EBITDA Ratio Last Year < 4.0 -0.22
Debt / EBITDA Ratio Last Quarter < 4.0 -0.22
Debt / NCAV Ratio Last Year < 2.0 0.25
Debt / NCAV Ratio Last Quarter < 2.0 0.43
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.2
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.25
Interest Coverage Ratio Ratio Last Year > 8.0 0.0
Interest Coverage Ratio Last Quarter > 8.0 0.0
FCF / Sales Ratio Last Year > 8.0% -1012
FCF / Sales Ratio Last Quarter > 8.0% 0.0

Growth

Metric Target Value
Earnings Yield > 12% -227.8
Ebit Yield Last Year > 12% -169.4
Ebit Yield Last Quarter > 12% -18.9
FCF Yield Last Year > 10% -134.9
FCF Yield Last Quarter > 10% 0.0
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.73
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.0

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -2.26
Altman Z-score Last Quarter ≥ 3.5 -3.1